Clinical trial

Brexpiprazole in Patients With Acute Schizophrenia

NCT01810380

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE3

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2017-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

PlaceboDRUG

BrexpiprazoleDRUG · verified · RxNorm: brexpiprazole

Quetiapine extended releaseDRUG

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

Otsuka Pharmaceutical Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01810380 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.